Source:http://linkedlifedata.com/resource/pubmed/id/12951065
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-9-2
|
pubmed:abstractText |
Interleukin-10 (IL-10), a potent antiinflammatory and immunosuppressive cytokine, plays an important role in the regulation of immune responses. To discover small molecules that stimulate IL-10 production, a cell-based screening assay was performed using a murine macrophage cell line, RAW264.7. Imidocarb, (3,3'-bis-2-imidazolin-2-yl)-carbanilide, which has been used as an anti-protozoan drug for the prevention and treatment of babesiosis in cattle, was thus identified. Imidocarb markedly enhanced LPS-induced IL-10 production not only by RAW264.7 cells but also by murine peritoneal macrophages in a concentration-dependent manner. It also augmented IL-10 production in the presence of zymosan, a yeast cell wall component. In contrast, imidocarb inhibited LPS-induced tumor necrosis factor (TNF)-alpha production by peritoneal macrophages. In mice, intraperitoneal administration of imidocarb significantly increased serum IL-10 levels and lowered TNF-alpha levels. Our results suggest that a novel anti-inflammatory property of imidocarb could lead to new therapeutic approaches in inflammatory conditions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiprotozoal Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Imidocarb,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Zymosan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-291X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
309
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
414-8
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12951065-Animals,
pubmed-meshheading:12951065-Antiprotozoal Agents,
pubmed-meshheading:12951065-Cell Line,
pubmed-meshheading:12951065-Dose-Response Relationship, Drug,
pubmed-meshheading:12951065-Female,
pubmed-meshheading:12951065-Imidocarb,
pubmed-meshheading:12951065-Interleukin-10,
pubmed-meshheading:12951065-Lipopolysaccharides,
pubmed-meshheading:12951065-Macrophages,
pubmed-meshheading:12951065-Mice,
pubmed-meshheading:12951065-Mice, Inbred BALB C,
pubmed-meshheading:12951065-Up-Regulation,
pubmed-meshheading:12951065-Zymosan
|
pubmed:year |
2003
|
pubmed:articleTitle |
Imidocarb, a potent anti-protozoan drug, up-regulates interleukin-10 production by murine macrophages.
|
pubmed:affiliation |
Daiichi Suntory Biomedical Research Co., Ltd., 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-8513, Japan.
|
pubmed:publicationType |
Journal Article
|